From: The role of radiotherapy in multimodal treatment of pancreatic carcinoma
Group - Study Year | Patients (n) | Inclusion criteria Resection-Status | Treatment arms | Median overall survival (Months) | p-value | Preoperative imaging |
---|---|---|---|---|---|---|
GITSG-1985[18] | 49 | R0 | CRT Observation | 21.0 10.9 | 0.005 | No |
EORTC-1999[22] | 114* | R0 | CRT Observation | 17.1 12.6 | 0.099 | No |
ESPAC-1-2004[17] | 289# | R0 or R1 | Cx No Cx& | 21.6 16.9 | Not available | No |
CONKO-001-2007[19] | 368 | R0 or R1 | Cx Observation | 22.1 20.2 | 0.06 | Yes |
RTOG 9704 2008[20] | 442^ | R0 or R1 | CRT + GEM CRT + 5-FU | 20.6 16.9 | 0.033 | Yes |